For the quarter ending 2025-08-31, STZ had -$1,900K decrease in cash & cash equivalents over the period. $634,800K in free cash flow.
| Cash Flow | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 |
|---|---|---|---|---|
| Net income (loss) | 486,100 | 523,800 | -370,600 | 629,100 |
| Goodwill and intangible assets impairment | - | - | 2,797,700 | - |
| Assets held for sale impairment | - | - | 478,000 | - |
| (gain) loss on sale of business | - | - | 281,100 | - |
| Unrealized net (gain) loss on securities measured at fair value | - | - | -47,900 | - |
| Amortization of debt issuance costs and loss on extinguishment of debt | - | - | -10,400 | - |
| Equity method investments impairment | - | - | 6,300 | 300 |
| Unrealized net (gain) loss on securities measured at fair value | - | - | - | 0 |
| Goodwill impairment | -2,250,000 | - | - | 0 |
| Assets held for sale impairment and related expenses | - | 52,100 | - | - |
| Asset impairment and related expenses | 52,100 | - | - | - |
| Deferred tax provision (benefit) | 243,600 | 34,000 | -26,100 | -5,700 |
| Depreciation | 102,700 | 105,200 | 105,900 | 119,000 |
| Stock-based compensation | 21,700 | 10,400 | 11,500 | 19,700 |
| Long-lived assets impairment | - | - | 0 | - |
| Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings | - | - | -20,400 | 23,900 |
| Gain (loss) on settlement of pre-issuance hedge contracts | - | - | 0 | - |
| Noncash lease expense | 31,600 | 31,000 | 27,200 | 27,500 |
| Net gain in connection with exchangeable shares | 0 | 0 | -37,500 | 44,700 |
| Accounts receivable | -146,100 | 73,900 | -98,000 | -32,900 |
| Inventories | 27,500 | 20,800 | 98,000 | 68,900 |
| Prepaid expenses and other current assets | 31,000 | 25,800 | 42,200 | -30,500 |
| Accounts payable | 16,300 | 36,700 | -15,900 | -17,100 |
| Deferred revenue | - | - | -45,200 | - |
| Contract liabilities | -56,700 | 6,300 | - | - |
| Other accrued expenses and liabilities | 35,300 | -92,300 | 68,500 | -62,000 |
| Other | -116,100 | 50,500 | -7,800 | -25,100 |
| Total adjustments | 366,000 | 113,400 | 965,300 | 56,100 |
| Net cash provided by (used in) operating activities | 852,100 | 637,200 | 594,700 | 685,200 |
| Purchase of property, plant, and equipment | 217,300 | 192,800 | 282,600 | 228,400 |
| Purchase of business, net of cash acquired | 0 | - | 0 | 400 |
| Investments in equity method investees and securities | 0 | 7,000 | 3,900 | 12,100 |
| Proceeds from sale of assets | 30,800 | 0 | 700 | 2,000 |
| Proceeds from sale of business | 847,400 | 3,700 | 409,200 | 0 |
| Other investing activities | 0 | 0 | 0 | 1,700 |
| Net cash provided by (used in) investing activities | 660,900 | -196,100 | 123,400 | -240,600 |
| Proceeds from issuance of long-term debt | 0 | 499,100 | 0 | 0 |
| Principal payments of long-term debt | 901,100 | 1,000 | 1,000 | 401,700 |
| Net proceeds from (repayments of) short-term borrowings | -125,000 | -429,200 | -83,400 | 382,000 |
| Dividends paid | 178,900 | 182,200 | 180,500 | 182,700 |
| Purchases of treasury stock | 297,900 | 306,100 | 455,700 | 218,900 |
| Proceeds from shares issued under equity compensation plans | -2,200 | 5,300 | 7,600 | 17,800 |
| Payments of minimum tax withholdings on stock-based payment awards | 100 | 9,400 | 0 | 0 |
| Payments of debt issuance, debt extinguishment, and other financing costs | 200 | 5,200 | 0 | 100 |
| Distributions to noncontrolling interests | 10,000 | 7,500 | 10,000 | 47,500 |
| Payment of contingent consideration | 100 | 1,400 | 0 | 0 |
| Purchase of noncontrolling interest | - | - | 0 | -16,300 |
| Payment to holders of class b stock in connection with the reclassification | - | - | 0 | - |
| Net cash provided by (used in) financing activities | -1,515,500 | -437,600 | -723,000 | -434,800 |
| Effect of exchange rate changes on cash and cash equivalents | 600 | 2,300 | -700 | -700 |
| Net increase (decrease) in cash and cash equivalents | -1,900 | 5,800 | -5,600 | 9,100 |
| Cash and cash equivalents at beginning of period | 73,900 | 68,100 | 73,700 | 64,600 |
| Cash and cash equivalents at end of period | 72,000 | 73,900 | 68,100 | 73,700 |
CONSTELLATION BRANDS, INC. (STZ)
CONSTELLATION BRANDS, INC. (STZ)